Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) FCF Margin (2021 - 2025)

Historic FCF Margin for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to 54.36%.

  • Biofrontera's FCF Margin fell 404400.0% to 54.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 32.19%, marking a year-over-year increase of 193200.0%. This contributed to the annual value of 27.63% for FY2024, which is 454700.0% up from last year.
  • Per Biofrontera's latest filing, its FCF Margin stood at 54.36% for Q3 2025, which was down 404400.0% from 34.15% recorded in Q2 2025.
  • In the past 5 years, Biofrontera's FCF Margin registered a high of 1.82% during Q2 2022, and its lowest value of 229.05% during Q4 2021.
  • Over the past 5 years, Biofrontera's median FCF Margin value was 42.75% (recorded in 2024), while the average stood at 61.72%.
  • In the last 5 years, Biofrontera's FCF Margin skyrocketed by 1474900bps in 2022 and then plummeted by -1783700bps in 2023.
  • Quarter analysis of 5 years shows Biofrontera's FCF Margin stood at 229.05% in 2021, then surged by 64bps to 81.56% in 2022, then fell by -3bps to 83.64% in 2023, then soared by 91bps to 7.64% in 2024, then crashed by -611bps to 54.36% in 2025.
  • Its FCF Margin was 54.36% in Q3 2025, compared to 34.15% in Q2 2025 and 47.97% in Q1 2025.